Back to Primary literature
Primary-literature peptidehigh evidence

PEPDIA-PLP-003969

RV-23

Aliases: pep_RV23, RV-23

Normalized sequence

RIGVLLARLPKLFSLFKLMGKKV

23 amino acids

Release PepDiana-V1-20260620

31

Activity records

2

Source papers

27

Positive

4

Negative / threshold

Cross-layer links

Related Integrated records

Versioned scientific descriptors

Physicochemical properties and standard representations

not calculated

Reported properties

No separate physicochemical property was reported in the primary-literature identity record. PepDiana release values are shown as computed properties.

Computed properties

physchem-20260620

Molecular weight

Not calculated

Molecular formula

Not calculated

Theoretical pI

Not calculated

Net charge at pH 7

Not calculated

GRAVY

Not calculated

Instability index

Not calculated

Aromaticity

Not calculated

Topological polar surface area

Not calculated

cLogP

Not calculated

Hydrogen-bond donors

Not calculated

Hydrogen-bond acceptors

Not calculated

Rotatable bonds

Not calculated

Method: Not recorded

Tool: Not recorded

Calculated: Not recorded

Sequence representations

representations-20260620

ProForma 2.0

Not calculated for this record

HELM 2.0

Not calculated for this record

Canonical SMILES

Not calculated for this record

Isomeric SMILES

Not calculated for this record

Paper-level observations

Experimental evidence grouped by activity

Antimicrobial 26 records

PMC12024264

26 observations
AntimicrobialAnti-BiofilmPositive observation
Record detail

RV-23 causes a total reduction in biofilm attachment at 50 and 12.5 μM for K. pneumoniae and E. coli, respectively.

Measure
biofilm_inhibition
Value
50 μM
Target
Klebsiella pneumoniae
Assay
Not reported by source
Source publication
AntimicrobialAnti-BiofilmPositive observation
Record detail

RV-23 causes a total reduction in biofilm attachment at 50 and 12.5 μM for K. pneumoniae and E. coli, respectively.

Measure
biofilm_inhibition
Value
12.5 μM
Target
Escherichia coli
Assay
Not reported by source
Source publication
AntimicrobialAntibacterialPositive observation
Record detail

According to the best antimicrobial activity evidenced for RV-23, its combination with meropenem provides the best results, with a MIC at 3.125 μM (peptide) and 0.625 μg/mL (antibiotic) against K. pneumoniae.

Measure
MIC
Value
3.125 μM (peptide) and 0.625 μg/mL (antibiotic)
Target
Klebsiella pneumoniae
Assay
Not reported by source
Source publication
AntimicrobialAntibacterialPositive observation
Record detail

According to the best antimicrobial activity evidenced for RV-23, its combination with meropenem provides the best results, with a MIC at ... 6.25 μM (peptide) and 2.5 μg/mL (antibiotic) against E. coli.

Measure
MIC
Value
6.25 μM (peptide) and 2.5 μg/mL (antibiotic)
Target
Escherichia coli
Assay
Not reported by source
Source publication
Antiviral 3 records

PMC10609114

3 observations
AntiviralGeneral AntiviralNegative / threshold
Record detail

On the contrary, no activity was observed after the viral adsorption step (post-treatment), indicating that the peptides did not interfere later in the infection.

Measure
percent_inhibition
Value
no activity
Target
Vero
Assay
Not reported by source
Source publication
Toxicity 2 records

PMC10609114

1 observations

PMC12024264

1 observations

Citation and release provenance

Cite this identity as PepDiana record PEPDIA-PLP-003969, release PepDiana-V1-20260620. Experimental observations retain their paper, mention, and activity-record identifiers.

Record updated: 2026-06-22T07:14:26.229247+00:00